[1]
“Rosuvastatin and ezetimibe in the treatment of diabetic dyslipidemia in patients with type 2 diabetes mellitus”, AJPMHS, vol. 2, no. 4, pp. 342–349, Apr. 2024, Accessed: Jan. 17, 2026. [Online]. Available: https://grnjournal.us/index.php/AJPMHS/article/view/4490